FDA investigates possible Vytorin link to cancer

August 23rd, 2008

(AP) -- Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer.

---

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

---

Similar stories from PHYSorg:

Trials find no benefits of Zetia

Jan 15, 2008 | 3.6 / 5 (12) | 0

FDA takes issue with Cheerios health claims

May 12, 2009 | 2 / 5 (1) | 1

Older adults at high risk for drug interactions

Dec 23, 2008 | not rated yet | 0

A scientific breakthrough on the control of the bad cholesterol

Nov 24, 2008 | 4.1 / 5 (20) | 0

Management strategies for high risk stroke patients poor in a majority of cases: study

Jun 08, 2009 | not rated yet | 0

• JerryPark - Aug 23, 2008
  • Current rank
  • 1
  • 2
  • 3
  • 4
  • 5
  • Rank: 5 / 5 (1)
  • rate
  Statins have been suspected of causing cancer for years. No one has really tried to determine if there is an association with increased cancer because such a link would likely result in decreased sales of statins.
  
  The known problems with statin therapy and the severe disability, organ failure and deaths they cause should be sufficient to limit sales, but they apparently do not limit sales.
  
  Of course, the advice in the article is to keep taking statins.
  • flag